This web site use private and third party cookies to optimize your navigation, suit your preferences and perform analytical tasks. By continuing browsing accept our Cookies Policy.

Accept
19 May 2020Brussels

The European Commission mobilises €122 additional funding for urgently needed research into the COVID-19

The Commission has mobilised another €122 million from its research and innovation programme, Horizon 2020, for urgently needed research into the coronavirus. The new call for expressions of interest contributes to the Commission's €1.4 billion pledge to the Coronavirus Global Response initiative, launched by President Ursula von der Leyen on 4 May 2020.

The projects funded under this call should repurpose manufacturing for rapid production of vital medical supplies and equipment needed for testing, treatment and prevention, as well as develop medical technologies and digital tools to improve detection, surveillance and patients care. New research will learn from large groups of patients (cohorts) across Europe and better understanding of the behavioural and socio-economic impacts of the coronavirus epidemic could help improve treatment and prevention strategies.

The deadline for submission is 11 June 2020, while the call will focus on delivering results quickly.

The new call will cover five areas with the following indicative budgets:

  • Repurposing of manufacturing for vital medical supplies and equipment (€23 million)
  • Medical technologies, Digital tools and Artificial Intelligence analytics to improve surveillance and care at high Technology Readiness Levels (€56 million)
  • Behavioural, social and economic impacts of the outbreak responses (€20 million)
  • Pan-European COVID-19 cohorts (€20 million)
  • Collaboration of existing EU and international cohorts of relevance to COVID-19 (€3 million)

You can consult the full press release here.